Expression of CD44 valiant isoforms has been reported to be correlated with
faster progression of neoplastic diseases metastasis ann reduced survival
period In this study! the correlation between the expression of CD44v2 (v2)
or CD44v6 (v6) and clinicopathological features was examined in Dukes B an
d C colorectal cancer using immunohistochemistry. V6 expression was not cor
related with any clinicopathological indices or-prognosis in either Dukes B
or C. On the other hand, v2 expression was correlated significantly with r
ecurrence rate and poorer prognosis in Dukes B colorectal cancer although t
here was no correlation between v2 expression and prognosis in Dukes C pati
ents. The results suggest that v2 is a candidate for a prognostic marker in
Dukes B colorectal cancer. CD44v2 expression may be an indication for adop
ting adjuvant chemotherapy in patients without lymph node metastasis.